Interestingly, Venneker et al. studied the expression of the membrane cofactor protein (MCP) and decay-accelerating factor (DAF) in the endothelium of skin biopsies of SSc patients, both in lesional and non-lesional samples, and in the endothelium of morphea lesions. This evidence concerns the gene CD46 and systemic sclerosis.